From gold to platinum sponsorship, our alliance with ISAPS has grown even stronger. Beginning of this year, BioScience became the ISAPS Platinum Sponsor and the only dermal filler company belonging to this category.

ISAPS is a global organization that brings together plastic surgeons and professionals in the field of aesthetic and cosmetic surgery. ISAPS focuses on promoting ethical and safe practices in aesthetic plastic surgery and provides a platform for education, research, and collaboration among professionals in the industry.

Our exclusive partnership with ISAPS since 2019 is built on two main values that they have in common: Excellence and Safety.

BioScience is particularly driven to ensure the highest standards of patient safety and scientific excellence while providing the highest-quality products.

We are very thrilled to strengthen our relationship with ISAPS, by providing education, safety guidelines, and personalized training with the help of internationally recognized plastic surgeons.

Embark on this journey with us, and stay tuned for the upcoming projects with ISAPS.

About ISAPS

ISAPS is the world’s leading professional body for board-certified aesthetic plastic surgeons. Founded in 1970, ISAPS membership includes the world’s best known and respected reconstructive and aesthetic plastic surgeons in over 100 countries on every continent, reflecting the true international mission of the organization.

About BioScience GmbH

Established in 2001, BioScience GmbH is a German manufacturer designing and producing medical devices based on hyaluronic acid. Today, they are one of the few manufacturers to offer monophasic and biphasic dermal fillers. 

Their two product lines – HYAcorp and Genefill, are certified with the CE mark and used for the full spectrum of facial and body applications in over 40 countries. BioScience’s commitment to innovation and excellence has earned the trust of the most recognized plastic surgeons and dermatologists, a network of over 65 distributors, and millions of satisfied patients.

‍